Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

144,523 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children and Adolescents from 2003 to 2023: a Plain Language Summary of Publication.
Stuurman AL, Enxing J, Gutiérrez AV, Gray CM, Sepúlveda-Pachón IT, Ubamadu E, Bandell A, Taylor S, El Azzi G, Meeraus W. Stuurman AL, et al. Among authors: taylor s. Ther Adv Infect Dis. 2025 Oct 17;12:20499361251390680. doi: 10.1177/20499361251390680. eCollection 2025 Jan-Dec. Ther Adv Infect Dis. 2025. PMID: 41132317 Free PMC article. Review.
Protection against COVID-19 hospitalisation conferred by primary-series vaccination with AZD1222 in non-boosted individuals: first vaccine effectiveness results of the European COVIDRIVE study and meta-regression analysis.
Meeraus W, de Munter L, Gray CM, Dwivedi A, Wyndham-Thomas C, Ouwens M, Hartig-Merkel W, Drikite L, Rebry G, Carmona A, Stuurman AL, Chi Nguyen TY, Mena G, Mira-Iglesias A, Icardi G, Otero-Romero S, Baumgartner S, Martin C, Taylor S, Bollaerts K. Meeraus W, et al. Among authors: taylor s. Lancet Reg Health Eur. 2023 Jul 1;31:100675. doi: 10.1016/j.lanepe.2023.100675. eCollection 2023 Aug. Lancet Reg Health Eur. 2023. PMID: 37547274 Free PMC article.
COVID-19 vaccine booster doses provide increased protection against COVID-19 hospitalization compared with previously vaccinated individuals: Interim findings from the REFORCO-Brazil real-world effectiveness study during Delta and Omicron.
Meeraus W, Stuurman AL, Durukal I, Conde-Sousa E, Lee A, Maria AS, Furtado BE, Ouwens M, Gray CM, Valverde DA, da Silva HG, Taylor S. Meeraus W, et al. Among authors: taylor s. Vaccine. 2023 Oct 6;41(42):6366-6378. doi: 10.1016/j.vaccine.2023.08.085. Epub 2023 Sep 12. Vaccine. 2023. PMID: 37704499 Free article.
AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: The RAVEN cohort study.
Meeraus W, Joy M, Ouwens M, Taylor KS, Venkatesan S, Dennis J, Tran TN, Dashtban A, Fan X, Williams R, Morris T, Carty L, Kar D, Hoang U, Feher M, Forbes A, Jamie G, Hinton W, Sanecka K, Byford R, Anand SN, Hobbs FDR, Clifton DA, Pollard AJ, Taylor S, de Lusignan S. Meeraus W, et al. Among authors: taylor s, taylor ks. J Infect. 2024 Apr;88(4):106129. doi: 10.1016/j.jinf.2024.106129. Epub 2024 Feb 29. J Infect. 2024. PMID: 38431156 Free article.
Effectiveness of the AZD1222 vaccine against COVID-19 hospitalization in Europe: final results from the COVIDRIVE test-negative case-control study.
de Munter L, Meeraus W, Dwivedi A, Mitratza M, Wyndham-Thomas C, Carty L, Ouwens M, Hartig-Merkel W, Drikite L, Rebry G, Casas I, Mira-Iglesias A, Icardi G, Otero-Romero S, Baumgartner S, Martin C, Holemans X, Ten Kate GL, Bollaerts K, Taylor S. de Munter L, et al. Among authors: taylor s. Eur J Public Health. 2025 Apr 1;35(2):373-378. doi: 10.1093/eurpub/ckae219. Eur J Public Health. 2025. PMID: 39836896 Free PMC article.
Second booster doses of adenoviral- and mRNA-based COVID-19 vaccines increase protection against COVID-19 hospitalization: Final analysis from the REFORCO-Brazil real-world effectiveness study during Omicron.
Meeraus W, Postema A, Gray CM, Lee A, Maria AS, Furtado BE, Conde-Sousa E, Ouwens M, Valverde DA, da Cunha CA, Barbosa AN, Corte C, Taylor S. Meeraus W, et al. Among authors: taylor s. Vaccine. 2025 Apr 19;53:126955. doi: 10.1016/j.vaccine.2025.126955. Epub 2025 Mar 10. Vaccine. 2025. PMID: 40068393 Free article.
Real-world effectiveness of live attenuated influenza vaccines (LAIV) and inactivated influenza vaccines (IIV) in children from 2003 to 2023: a systematic literature review and network meta-analysis.
Stuurman AL, Enxing J, Gutiérrez AV, Gray CM, Sepúlveda-Pachón IT, Ubamadu E, Bandell A, Taylor S, El Azzi G, Meeraus W. Stuurman AL, et al. Among authors: taylor s. Expert Rev Vaccines. 2025 Dec;24(1):703-725. doi: 10.1080/14760584.2025.2536087. Epub 2025 Jul 30. Expert Rev Vaccines. 2025. PMID: 40697050 Free article.
Implementation of AZD7442 (Tixagevimab/Cilgavimab) COVID-19 Pre-exposure Prophylaxis (PrEP) in the Largest Health Maintenance Organization in Israel: Real-world Uptake and Sociodemographic and Clinical Characteristics Across Immunocompromised Patient Groups.
Hayek S, Levy J, Shaham G, Dagan N, Serby D, Duskin-Bitan H, Yarden A, Ferreira C, Livnat I, Dube S, Taylor S, Venkatesan S, Balicer RD, Netzer D, Peretz A. Hayek S, et al. Among authors: taylor s. Infect Dis Ther. 2024 Jun;13(6):1379-1389. doi: 10.1007/s40121-024-00981-8. Epub 2024 May 10. Infect Dis Ther. 2024. PMID: 38728006 Free PMC article.
Effectiveness of AZD7442 (Tixagevimab/Cilgavimab) for Pre-Exposure Prophylaxis Against COVID-19 Hospitalization in Israel During the Omicron Sub-Variant Time Period.
Hayek S, Levy J, Shaham G, Dagan N, Serby D, Duskin-Bitan H, Dube S, Ferreira C, Livnat I, Talarico C, Taylor S, Venkatesan S, Yarden A, Balicer RD, Netzer D, Peretz A. Hayek S, et al. Among authors: taylor s. Infect Dis Ther. 2025 Feb;14(2):433-445. doi: 10.1007/s40121-024-01100-3. Epub 2025 Jan 7. Infect Dis Ther. 2025. PMID: 39762664 Free PMC article.
144,523 results
You have reached the last available page of results. Please see the User Guide for more information.